ARTICLE | Company News
Agenus, PharmLogic LLC, Cornell University deal
October 7, 2013 7:00 AM UTC
Agenus granted the VaxLogic LLC subsidiary of university healthcare investment firm PharmLogic a non-exclusive license to use Agenus' QS-21 Stimulon adjuvant to develop a nicotine addiction vaccine. ...